Retatrutide

Retatrutide (CAS 2381089-83-2) is a synthetic triple-agonist peptide supplied for laboratory and analytical research use only. It is one of the most widely studied compounds in current metabolic research, notable for its simultaneous activity at three receptor targets.

Research background

Retatrutide is characterised in the literature as a triple agonist acting on the GLP-1, GIP and glucagon receptors. This three-receptor profile distinguishes it from single-agonist and dual-agonist compounds, and is the primary reason it has become a subject of interest in metabolic and energy-balance research models. Investigators typically study it in the context of receptor signalling pathways, glucose regulation mechanisms and comparative agonist activity.

Specifications

• Compound: Retatrutide
• CAS number: 2381089-83-2
• Appearance: Lyophilised white powder
• Purity: 99%+ verified by HPLC-MS
• Available sizes: 10mg, 20mg, 30mg, 40mg, 50mg
• Presentation: Sealed, tamper-evident vial

Testing and verification

Every batch is independently analysed by a third-party laboratory using HPLC-MS to confirm identity, quantity and purity. Each lot is assigned a unique batch identifier and published with its corresponding Certificate of Analysis on our Lab Results page, so the exact paperwork for the batch you receive can be reviewed before a vial is ever opened.

Handling and storage

Supplied lyophilised for stability in transit. Store the sealed vial cold and protected from light. Standard laboratory handling practices apply.

Research use only. This material is intended strictly for laboratory and analytical research. It is not a medicine, supplement or therapeutic good, and is not for human or veterinary consumption.